Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 100800
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.100800
Table 2 Incidence of grade III-IV adverse events, n (%)
General data
Control group (n = 45)
Research group (n = 54)
χ2
P value
Gastrointestinal reaction4 (8.89)3 (5.56)
Renal function impairment 2 (4.44)2 (3.70)
Liver function impairment 2 (4.44)1 (1.85)
Myelosuppression1 (2.22)1 (1.85)
Total9 (20.00)7 (12.96)0.8970.344